| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.23 |
0.4 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.16 |
0.6 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.003 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.005 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
| mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.03 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.007 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |